AAAAAA

   
Results: 1-25 | 26-50 | 51-60
Results: 26-50/60

Authors: McCluskie, MJ Weeratna, RD Krieg, AM Davis, HL
Citation: Mj. Mccluskie et al., CpG DNA is an effective oral adjuvant to protein antigens in mice, VACCINE, 19(7-8), 2000, pp. 950-957

Authors: Krieg, AM
Citation: Am. Krieg, Immune effects and mechanisms of action of CpG motifs, VACCINE, 19(6), 2000, pp. 618-622

Authors: Davis, HL Suparto, I Weeratna, R",Jumintarto,"Iskandriati, D Chamzah, S Ma'ruf, A Nente, C Pawitri, D Krieg, AM",Heriyanto,"Smits, W Sajuthi, D
Citation: Hl. Davis et al., CpG DNA overcomes hyporesponsiveness to hepatitis B vaccine in orangutans, VACCINE, 18(18), 2000, pp. 1920-1924

Authors: Krieg, AM Wagner, H
Citation: Am. Krieg et H. Wagner, Causing a commotion in the blood: immunotherapy progresses from bacteria to bacterial DNA, IMMUNOL TOD, 21(10), 2000, pp. 521-526

Authors: Krieg, AM Kline, JN
Citation: Am. Krieg et Jn. Kline, Immune effects and therapeutic applications of CpG motifs in bacterial DNA, IMMUNOPHARM, 48(3), 2000, pp. 303-305

Authors: Krieg, AM Hartmann, G Yi, AK
Citation: Am. Krieg et al., Mechanism of action of CpG DNA, CURR T MICR, 247, 2000, pp. 1-21

Authors: Askew, D Chu, RS Krieg, AM Harding, CV
Citation: D. Askew et al., CpG DNA induces maturation of dendritic cells with distinct effects on nascent and recycling MHC-II antigen-processing mechanisms, J IMMUNOL, 165(12), 2000, pp. 6889-6895

Authors: Warren, TL Bhatia, SK Acosta, AM Dahle, CE Ratliff, TL Krieg, AM Weiner, GJ
Citation: Tl. Warren et al., APC stimulated by CpG oligodeoxynucleotide enhance activation of MHC classI-restricted T cells, J IMMUNOL, 165(11), 2000, pp. 6244-6251

Authors: Brunner, C Seiderer, J Schlamp, A Bidlingmaier, M Eigler, A Haimerl, W Lehr, HA Krieg, AM Hartmann, G Endres, S
Citation: C. Brunner et al., Enhanced dendritic cell maturation by TNF-alpha or cytidine-phosphate-guanosine DNA drives T cell activation in vitro and therapeutic anti-tumor immune responses in vivo, J IMMUNOL, 165(11), 2000, pp. 6278-6286

Authors: Hartmann, G Weeratna, RD Ballas, ZK Payette, P Blackwell, S Suparto, I Rasmussen, WL Waldschmidt, M Sajuthi, D Purcell, RH Davis, HL Krieg, AM
Citation: G. Hartmann et al., Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo, J IMMUNOL, 164(3), 2000, pp. 1617-1624

Authors: Hartmann, G Krieg, AM
Citation: G. Hartmann et Am. Krieg, Mechanism and function of a newly identified CpG DNA moth in human primaryB cells, J IMMUNOL, 164(2), 2000, pp. 944-952

Authors: Battafarano, DF Enzenauer, RJ Older, SA Krieg, AM
Citation: Df. Battafarano et al., Exacerbation of systemic lupus erythematosus after hepatitis B vaccination: comment on the article by Battafarano et al and the letter by Senecal et al - Reply, ARTH RHEUM, 43(2), 2000, pp. 468-469

Authors: Weeratna, R Krieg, AM Davis, HL
Citation: R. Weeratna et al., Immunostimulatory CpG motifs and DNA vaccines, METH MOL M, 29, 2000, pp. 169-172

Authors: Krieg, AM
Citation: Am. Krieg, Direct immunologic activities of CpG DNA and implications for gene therapy, J GENE MED, 1(1), 1999, pp. 56-63

Authors: Krieg, AM Stein, CA
Citation: Am. Krieg et Ca. Stein, Antisense and nucleic acid-based therapeutics: The next millennium, ANTISENSE N, 9(6), 1999, pp. 495-495

Authors: Krieg, AM
Citation: Am. Krieg, Immune stimulation by CpG DNA, ANTISENSE N, 9(4), 1999, pp. 429-431

Authors: Jakob, T Walker, PS Krieg, AM von Stebut, E Udey, MC Vogel, JC
Citation: T. Jakob et al., Bacterial DNA and CpG-containing oligodeoxynucleotides activate cutaneous dendritic cells and induce IL-12 production: Implications for the augmentation of Th1 responses, INT A AL IM, 118(2-4), 1999, pp. 457-461

Authors: Hartmann, G Krieg, AM
Citation: G. Hartmann et Am. Krieg, CpG DNA and LPS induce distinct patterns of activation in human monocytes, GENE THER, 6(5), 1999, pp. 893-903

Authors: Yi, AK Peckham, DW Ashman, RF Krieg, AM
Citation: Ak. Yi et al., CpG DNA rescues B cells from apoptosis by activating NF kappa B and preventing mitochondrial membrane potential disruption via a chloroquine sensitive pathway, INT IMMUNOL, 11(12), 1999, pp. 2015-2024

Authors: Jones, TR Obaldia, N Gramzinski, RA Charoenvit, Y Kolodny, N Kitov, S Davis, HL Krieg, AM Hoffman, SL
Citation: Tr. Jones et al., Synthetic oligodeoxynucleotides containing CpG motifs enhance immunogenicity of a peptide malaria vaccine in Aotus monkeys, VACCINE, 17(23-24), 1999, pp. 3065-3071

Authors: Krieg, AM
Citation: Am. Krieg, Mechanisms and applications of immune stimulatory CpG oligodeoxynucleotides, BBA-GENE ST, 1489(1), 1999, pp. 107-116

Authors: Krieg, AM Yi, AK Hartmann, G
Citation: Am. Krieg et al., Mechanisms and therapeutic applications of immune stimulatory CpG DNA, PHARM THERA, 84(2), 1999, pp. 113-120

Authors: Ramachandra, L Chu, RS Askew, D Noss, EH Canaday, DH Potter, NS Johnsen, A Krieg, AM Nedrud, JG Boom, WH Harding, CV
Citation: L. Ramachandra et al., Phagocytic antigen processing and effects of microbial products on antigenprocessing and T-cell responses, IMMUNOL REV, 168, 1999, pp. 217-239

Authors: Kline, JN Krieg, AM Waldschmidt, TJ Ballas, ZK Jain, V Businga, TR
Citation: Jn. Kline et al., CpG oligodeoxynucleotides do not require T-H1 cytokines to prevent eosinophilic airway inflammation in a murine model of asthma, J ALLERG CL, 104(6), 1999, pp. 1258-1264

Authors: Older, SA Battafarano, DF Enzenauer, RJ Krieg, AM
Citation: Sa. Older et al., Can immunization precipitate connective tissue disease? Report of five cases of systemic lupus erythematosus and review of the literature, SEM ARTH RH, 29(3), 1999, pp. 131-139
Risultati: 1-25 | 26-50 | 51-60